End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.41 USD | +3.97% | +10.68% | 0.00% |
Jun. 24 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
May. 30 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) added to S&P TMI Index | CI |
Financials (USD)
Sales 2022 | 1.32M | Sales 2023 | 1.63M | Capitalization | 209M |
---|---|---|---|---|---|
Net income 2022 | -115M | Net income 2023 | -155M | EV / Sales 2022 * | - |
Net cash position 2022 * | - | Net cash position 2023 * | - | EV / Sales 2023 * | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | 173 |
Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 0% |
1 day | +3.97% | ||
1 week | +10.68% | ||
Current month | +1.69% | ||
1 month | -8.22% |
Date | Price | Change | Volume |
---|---|---|---|
24-07-16 | 14.41 | +3.97% | 194,420 |
24-07-15 | 13.86 | +4.29% | 170,989 |
24-07-12 | 13.29 | +0.30% | 53,283 |
24-07-11 | 13.25 | +2.16% | 79,502 |
24-07-10 | 12.97 | -0.38% | 95,367 |
End-of-day quote Nasdaq, July 15, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 209M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.61% | 32.76B | |
+79.34% | 29.46B | |
-12.20% | 16.31B | |
+3.35% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- INBX Stock